NCT06780540 Testing and Evaluating a Psychoeducation Tool and Guidelines for Victims of Violence in Belgian Hospitals.
| NCT ID | NCT06780540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Enhance Care to Victims of Violence |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-08-24 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2024-08-24 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The "Operation Alert/Operatie Alert/Opération Alerte" project, developed by UGent-ICRH and UZGent with funding from the Belgian Federal Public Service for Health, focuses on strengthening basic competencies to better and more quickly identify signs of violence. It also aims to provide victim-centered care and refer to specialized services when necessary. This initiative combines training for healthcare providers with practical tools, such as a psycho-education tool and clinical guidelines, to enhance care delivery. Below is an overview of the project's main components: Sub-Study 1: Psycho-education Tool * Objective: Develop and evaluate a tool to support healthcare providers and patients in understanding and addressing sexual and domestic violence, trauma, and their impacts on well-being. * Tool Description: A set of cards presented in a calendar format, featuring illustrations on one side and explanatory text on the other. Target Groups: Healthcare providers and victims/patients. * Development process: The tool was developed based on literature and input from experts and stakeholders during regular meetings. * Testing Phase: The tool will undergo a pilot study in selected hospitals and non-profit organizations (NGOs) working with victims of violence. * Evaluation: The tool's acceptability, usability, and relevance to the recovery process will be assessed through feedback collected via questionnaires from both healthcare providers and victims/patients. Sub-Study 2: Guidelines Older Adults * Objective: Develop and implement guidelines for screening violence among older adults and providing appropriate care for victims of various forms of violence (psychological, physical, (socio-)economic, and sexual). * Tool Description: A guideline that includes a screening protocol, care and referral pathways, and theoretical background on the topic. * Target Group: Older adults with sufficient cognitive abilities. * Development Process: The guidelines are informed by a literature review, expert, and stakeholder input through regular meetings and focus groups, and a pilot study involving cognitively capable older adults in the geriatric departments of four hospitals. * Testing Phase: The screening protocol is integrated into standard care procedures, such as intake interviews or geriatric assessments. It is implemented by multidisciplinary professionals, including physicians, nurses, psychologists, occupational therapists, and social workers. * Evaluation: Feedback on the guidelines is collected from healthcare providers via questionnaires. Older adults themselves are not directly involved in the evaluation, as the screening protocol is intentionally embedded discreetly within standard care procedures. Training and Support The project includes a robust training component delivered through educational online modules designed to equip healthcare providers with the knowledge and skills necessary to effectively use the tools and guidelines developed. Languages and Application The study materials and procedures are conducted in both French and Dutch, reflecting Belgium's bilingual context. Significance This project highlights the importance of tailored support for victims of violence and a systematic approach to care within clinical settings.
Eligibility Criteria
Inclusion Criteria: Substudy 1: Psycho-education Tool * Healthcare Providers: In-hospital healthcare providers who used the psycho-education tool during the pilot phase with a victim of violence. * Victims/Patients: Victims of violence aged 16 years or older who received psycho-education from an in-hospital healthcare provider during the pilot phase. Substudy 2: Guideline * Healthcare Providers: In-hospital healthcare providers who used the guideline during the pilot phase with an older adult. * Older Adults/Patients: Older adults with sufficient cognitive abilities who were admitted to the geriatric department (either for a day clinic or a longer stay). Exclusion Criteria: Substudy 1: Psycho-education tool * Victims under the age of 16. Substudy 2: Guideline * Older adults with cognitive impairments.
Contact & Investigator
Ines Keygnaert, Ph.D
PRINCIPAL INVESTIGATOR
Ghent University Hospital and Ghent University (VIORESC)
Frequently Asked Questions
Who can join the NCT06780540 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Enhance Care to Victims of Violence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06780540 currently recruiting?
Yes, NCT06780540 is actively recruiting participants. Contact the research team at charlotte.boven@uzgent.be for enrollment information.
Where is the NCT06780540 trial being conducted?
This trial is being conducted at Antwerp, Belgium, Antwerp, Belgium, Brussels, Belgium, Brussels, Belgium and 6 additional locations.
Who is sponsoring the NCT06780540 clinical trial?
NCT06780540 is sponsored by University Hospital, Ghent. The principal investigator is Ines Keygnaert, Ph.D at Ghent University Hospital and Ghent University (VIORESC). The trial plans to enroll 600 participants.